The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genmab
Patents, Royalties, Other Intellectual Property - P158-US-PSP3 - provisional filing
Subcutaneous epcoritamab in patients with relapsed/refractory B-cell non-Hodgkin lymphoma: Safety profile and antitumor activity.
 
Michael Roost Clausen
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences
 
Pieternella Lugtenburg
Consulting or Advisory Role - Celgene; Genmab; Roche/Genentech; SERVIER; Takeda
Research Funding - SERVIER (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Celgene
 
Martin Hutchings
Consulting or Advisory Role - Genmab; Janssen; Roche; Takeda
Research Funding - Celgene (Inst); Genmab (Inst); Janssen (Inst); Novartis (Inst); Roche (Inst); Takeda (Inst)
 
Peter W. M. Johnson
Honoraria - Bristol-Myers Squibb; Genmab; immunocore; Kymera; Novartis; Takeda
Consulting or Advisory Role - Epizyme; Janssen; Oncimmune
Research Funding - Epizyme (Inst)
Patents, Royalties, Other Intellectual Property - Combined use of Fc gamma RIIb (CD32b) and CD20 - specific antibodies. WO Patent, PCT/GB2011/051572; EU11760819.0
 
Kim M. Linton
No Relationships to Disclose
 
David John Lewis
No Relationships to Disclose
 
Martine Chamuleau
No Relationships to Disclose
 
Anna Sureda Balari
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
David Cunningham
Stock and Other Ownership Interests - OVIBIO
Consulting or Advisory Role - OVIBIO
Research Funding - 4SC (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); Clovis Oncology (Inst); Leap Oncology (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Roche (Inst)
 
Brian Elliott
No Relationships to Disclose
 
Dena DeMarco
Employment - Genmab
Patents, Royalties, Other Intellectual Property - Provisional filing
 
Kuo-mei Chen
Employment - Genmab
 
Rogier Mous
No Relationships to Disclose